Projects per year
Personal profile
Chinese Name
禹志領
Biography
Prof. Yu received his undergraduate education at the Henan University of Traditional Chinese Medicine, and obtained his PhD degree in biochemistry from the Hong Kong University of Science and Technology. Before joining the Hong Kong Baptist University, Prof. Yu once worked at China Pharmaceutical University, Nagasaki University, Hong Kong University of Science and Technology, Xiamen University and University of Macau. Prof. Yu is known for his research in herbal pharmacology, and in processing of Chinese medicinal materials. He has published more than 200 peer-reviewed research papers.
Consun Pharmaceutical Group Limited and Laboratory JaneClare Limited in collaboration with Prof. Yu's team established "Consun Chinese Medicines Research Centre for Renal Diseases" and "JaneClare Transdermal TCM Therapy Laboratory", respectively, in Hong Kong Baptist University.
Prof. Yu serves as Editorial Board Member/Associate Editor/Executive Editor/ Consulting Editor for more than 30 journals, e.g. LiShizhen Medicine and Materia Medica Research, BMC Complementary Medicine and Therapies, Current Topics in Nutraceutical Research, Journal of Alternative, Complementary & Integrative Medicine, Pharmacological Research.
Research Interests
1) Pharmacology of Chinese medicines, focusing on the mechanisms of action of anticancer, anti-inflammation and melanogenesis-modulation herbs; 2) Unique processing of Chinese medicinal herbs, focusing on the mechanisms underlying processing of Chinese medicines, standardization of adjuvant materials for the processing of Chinese medicinal herbs, and quality control of decoction pieces.
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
Dive into the research topics where Zhiling YU is active. Topic labels come from the works of this scholar.
- 1 Similar Scholars
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Targeting PAX2: A Novel Therapeutic Strategy for Rectal Cancer as an Aging-Related Disease
YU, Z. (PI)
1/11/25 → 31/10/28
Project: Research project
-
靶向DNA复制起始蛋白的共同转录因子PAX2治疗癌症 Targeting PAX2, a common transcriptional regulator of DNA replication-initiation proteins, for treating cancer
YU, Z. (PI), FU, X. (CoI), WANG, L. (CoI), WANG, X. (CoI) & WU, J. (CoI)
1/01/24 → 31/12/26
Project: Research project
-
Does dihydroartemisinin overcome vemurafenib resistance in melanoma by suppressing FLI1 expression?
YU, Z. (PI)
1/01/23 → …
Project: Research project
-
Ginsenoside Rg3 and Artesunate Synergistically Overcome Sorafenib Resistance in Hepatocellular Carcinoma: Pharmacological Effects and Mechanisms of Action
YU, Z. (PI)
1/12/22 → 30/11/25
Project: Research project
-
基於miR-142-3p/FAM98A通路研究槐花散抗結直腸癌的機制
YU, Z. (PI), CHEN, Y. (CoI), WU, Y. (CoI), AMIN, A. (CoI), WU, J. (CoI), WANG, X. (CoI) & LI, S. M. A. (CoI)
1/01/22 → 31/12/25
Project: Research project
-
Alisol B alleviates MASLD by activating liver autophagy and fatty acid oxidation via Ces2a
Zhang, C., Chen, L., Jiang, Y., Qiu, J., Lin, Y., Ren, G., Xu, F., Xi, J., Yu, Z., Rong, X. & Dou, X., 5 Jun 2025, In: International Immunopharmacology. 157, 14 p., 114768.Research output: Contribution to journal › Journal article › peer-review
1 Citation (Scopus) -
Alisol B ameliorated metabolic dysfunction-associated steatotic liver disease via regulating purine metabolism and restoring the gut microbiota disorders
Yiyou, L. (Co-first author), Congcong, Z. (Co-first author), Guilin, R. (Co-first author), Jiannan, Q., Yilong, F., Fucai, L., Qingsheng, L., Zhiling, Y., Lin, C. & Xiaobing, D., Sept 2025, In: Phytomedicine. 145, 19 p., 156992.Research output: Contribution to journal › Journal article › peer-review
-
A tri-compound formula comprising ginsenoside Rg1, tetrandrine and icariin alleviates atopic dermatitis symptoms in a mouse model
Wu, Y., Wang, X.-Q., Wu, J.-Y., Chen, Y.-J., Bai, J.-X., Li, A.S.-M., Fan, X.-Y., Wong, L.-Y., Wang, L., Fu, X.-Q. & Yu, Z.-L., Jun 2025, In: Phytomedicine. 141, 21 p., 156737.Research output: Contribution to journal › Journal article › peer-review
Open Access1 Citation (Scopus) -
Development of a Modular Ribonucleoprotein Complex as a General Strategy to Deliver RNAi Therapeutics
Tam, N. Y., Wang, X., Chan, G. C. Y., Kong, W. P., Chau, W. Y., Fu, X., Wong, K. Y., Lung, H. L., Yu, Z. L. & Aik, W. S., 26 Sept 2025, In: Advanced Healthcare Materials. 14, 25, 13 p., e03281.Research output: Contribution to journal › Journal article › peer-review
Open Access -
Dietary supplementation with milk-derived Bifidobacterium animalis subsp. lactis relieves colitis-linked reproductive disorders via gut-testis axis
Lin, J., Yin, L., Fan, Y., Yu, Z., Ma, X., Fu, X., Zhang, Y., Tang, S. & Chen, J., Mar 2025, In: iMetaOmics. 2, 1, 19 p., e49.Research output: Contribution to journal › Journal article › peer-review
Open Access
Prizes
-
File
-
Certificate for Excellence for an abstract presented at the 2022 World Federation of Chinese Medicine Societies Meeting
FAN, X. (Recipient), WU, Y. (Recipient), FU, X. (Recipient) & YU, Z. (Recipient), 23 Jun 2023
Prize: Award
File
Activities
-
灵芝改善睡眠的有效成分研究
YU, Z. (Speaker)
12 Apr 2024Activity: Conference/talk/lecture/symposium/speech/workshop, etc › Event organized by non-HKBU units
-
药食同源中草药在认知障碍中的应用
YU, Z. (Speaker)
7 Jun 2024Activity: Conference/talk/lecture/symposium/speech/workshop, etc › Event organized by non-HKBU units
-
Current Traditional Medicine (Journal)
YU, Z. (Member of editorial board)
Jan 2024 → …Activity: Publication peer-review/editorial work › Editor/reviewer for publications (incl. CDCF T61 Journal Editor)
-
Molecular mechanisms of TCM to treat cancer.
YU, Z. (Speaker)
24 Aug 2024Activity: Conference/talk/lecture/symposium/speech/workshop, etc › Event organized by non-HKBU units
-
Oncology Research (Journal)
YU, Z. (Member of editorial board)
20 Feb 2024 → …Activity: Publication peer-review/editorial work › Editor/reviewer for publications (incl. CDCF T61 Journal Editor)